Remel, Inc 2025-02-26 Health serious FDA
Health · FDA · Recall #FDA-Z-1201-2025
remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use Recall
Issued February 26, 2025 · Remel, Inc
In February 2025, Remel, Inc recalled the remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Product may contain surface and subsurface contamination of Listeria monocytogenes which is typically visible immediately upon removal from the packaging, appearing on the blood side of the biplate.
What you should do
- 1 Stop using remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Remel, Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Remel, Inc
- Category
- Health
- Recall date
- February 26, 2025
- Units affected
- Not reported
- Sold at
- US Nationwide distribution.
- Recall number
- FDA-Z-1201-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Remel, Inc has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.